Propell, an Australia/New Zealand leader in remote patient monitoring devices, is proud to announce a strategic collaboration with Xandar Kardian, a pioneer in radar-based continuous monitoring solutions. This collaboration will bring advanced, contact-free patient monitoring to hospitals and aged care facilities, enhancing patient care and staff efficiency.

Xandar Kardian’s revolutionary technology utilises radar sensors to provide 24/7 continuous monitoring of vital signs, including heart and respiratory rates, without the need for patient contact. By offering this state-of-the-art solution into various healthcare settings, Propell aims to improve early detection of patient deterioration, optimise care delivery and reduce the burden on staff.

Craig Simmonds, CEO and Founder of Propell, emphasised the impact of this technology on the demands of the workforce. “With more patients needing to be monitored with a stretched workforce, this innovative solution helps many patients’ vital signs to be autonomously monitored. Xandar Kardian is designed to assist in identifying patient deterioration before it worsens enabling clinicians to act, potentially avoid patient hospitalisations and free up staff time and resources for other tasks.

This collaboration aligns with Propell’s mission to equip healthcare providers with cutting-edge scale-able technology that improves patient outcomes and streamline operations. Xandar Kardian’s technology has been clinically validated to enhance patient care by providing accurate, real-time monitoring without requiring any wearables or physical contact.